Cretostimogene grenadenorepvec

瑞艾若司亭基

Report date: 2026/03/17 20:00:15

Base Information

Drug NameCretostimogene grenadenorepvec
Drug Alias NameCG-0070
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionGranulocyte-macrophage colony-stimulating factor receptor stimulants
TargetsGranulocyte-macrophage colony-stimulating factor receptor
Therapy Area/IndicationsSolid tumoursUrinary Bladder NeoplasmsUrologic Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesTaiwan +[7] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesCg Oncology Inc
China Registration ClassN/A

Develop Information

Active CompaniesH Lee Moffitt Cancer Center & Research InstituteLepu Biopharma Co LtdFujifilm Diosynth Biotechnologies Texas Llc +[5] 
Inactive CompaniesBiosante Pharmaceuticals Inc
Active IndicationsUrinary Bladder NeoplasmsUrologic NeoplasmsCarcinoma, Transitional Cell
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksDrugBank